Max Healthcare, Monash University Sign MoU to Launch Joint Medical Research, TNBC Program

The partnership’s first major initiative will focus on triple-negative breast cancer (TNBC), one of the most aggressive breast cancer subtypes with limited targeted treatment options.

Max Healthcare and Monash University have signed a Memorandum of Understanding (MoU) to establish a long-term research and academic collaboration aimed at advancing discovery science, clinical studies, and structured training programmes.

The partnership’s first major initiative will focus on triple-negative breast cancer (TNBC), one of the most aggressive breast cancer subtypes with limited targeted treatment options.

The agreement sets up a collaborative framework covering research across communicable and non-communicable diseases, while prioritising the development of a translational research pipeline. The TNBC initiative is expected to integrate Monash University’s scientific expertise with Max Healthcare’s clinical ecosystem to support faster movement of laboratory insights into clinical practice.

Senior leaders from both institutions, Dr. Sandeep Budhiraja, Group Medical Director at Max Healthcare, and Professor Roger Daly, Joint Head of Monash University’s Biomedicine Discovery Institute, were present during the signing. They highlighted the potential of the collaboration to strengthen precision research, expand clinical evidence generation, and build an advanced research-led workforce.

As part of the MoU, Max Healthcare and Monash University will co-develop academic and research programmes, including joint projects, co-authored publications, and interdisciplinary engagements. The agreement also introduces mechanisms for staff and student exchange to enhance scientific collaboration and broaden exposure to global research environments.

The institutions plan to scale capacity-building initiatives through shared education modules and structured training for clinicians, researchers, and students. The collaboration aims to create an integrated environment where scientific teams and clinicians work together to address high-burden diseases and support the development of emerging medical talent.

With TNBC as the starting point, the institutions aim to expand the joint research portfolio to additional disease areas in the upcoming phases.

Stay tuned for more such updates on Digital Health News